Sep 2026· Future Journal of Pharmaceuticals and Health Sciences· 0 citations
TL;DR
The present study delves into the significant contributions that artificial intelligence (AI) has made to the field of cancer, and specifically highlights the applications of AI in diagnosis, personalized treatment, and clinical trial optimization.
Abstract
Cancer is a major worldwide health concern, necessitating the development of novel strategies to improve detection and treatment outcomes. The present study delves into the significant contributions that artificial intelligence (AI) has made to the field o f cancer. It specifically highlights the applications of AI in diagnosis, personalized treatment, and clinical trial optimization. Diagnostic procedures have been transformed by recent advances in AI, particularly through the use of machine learning and de ep learning techniques. AI systems are becoming more and more accurate at interpreting medical imaging, including radiographs and histopathology slides, often outperforming human specialists in this regard. Furthermore, by combining genetic, lifestyle, and environmental data, AI - driven predictive models are showing promise in determining a person's risk of developing cancer. Artificial intelligence is a key factor in the advancement of personalized medicine in the field of cancer treatment. AI can assist me dical professionals in determining the best course of action for each patient by combining vast datasets from clinical trials and genomic research. Furthermore, AI is expediting the process of finding new drugs and repurposing old ones for cancer therapies . Additionally, this review discusses ethical concerns about the use of AI, such as algorithmic bias and privacy concerns pertaining to patient data. The application of AI technologies in oncology emphasises how important it is to have strong regulatory fr ameworks in place to guarantee patient safety and fair access to treatment.
The use of artificial intelligence (AI) models for gastric cancer prevention shows promise beyond traditional diagnostic approaches. Modern digital technologies can be applied to global healthcare. The implementation of deep machine learning has significantly increased the efficiency of computer vision. The introductio...
S. Kotelevets· Artificial Intelligence in C...· 0 citations
Breast cancer (BC) remains a major etiology of motility for female gender in the world, accounting for more than 2.3 million new fatalities annually. Despite early detection and treatment advancements, significant challenges persist, particularly in personalized management and preventive interventions. Recent technolog...
Esther Ayodeji-Ojo, Phebean Opeyemi Ojo, Vincent Oluwaseun Awe et al.· International Journal of Lat...· 0 citations
The fast evolution of artificial intelligence (AI) technology has brought about drastic changes in the field of medicine. In particular, when it comes to early disease diagnostics, systems based on machine learning, deep learning and large language models present an accurate and swift alternative to the conventional di...
Alikhan I. Rzaguliyev, Fidan Arzumanova· BIO Web of Conferences· 0 citations
Artificial intelligence (AI) is increasingly transforming cancer management by enabling the analysis of complex multimodal data generated across the cancer care continuum. This structured narrative review synthesizes current applications of AI, machine learning, and deep learning in cancer detection, imaging diagnosis,...
Eva Rahman Kabir, N. Mustafa, Zara Sheikh et al.· Discover Applied Sciences· 0 citations
Breast cancer is still one of the most significant global contributors to cancer-related deaths. Artificial intelligence (AI) applications in imaging, diagnostic imaging and assistance, systemic treatment and personalization, and predictive modeling are all part of the fast-growing field of breast cancer care. This rev...
Roshan Sah, Tanya Jain, Prachee Raje Bisht et al.· Current Drug Research Review...· 0 citations
This narrative review summarizes recent AI contributions across four interrelated dimensions: differential diagnosis and pattern recognition; prognosis and risk stratification; therapeutic discovery and drug repositioning; and the operational organization of rare disease care.
Mario A. Parra-Vilchis, A. F. Garibaldi-Ríos, M. Gallegos-Arreola et al.· Archives of Medical Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.